| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $59K | +0.0% | +0.0% |
| R&D Expense | $2K | -98.9% | — |
| SG&A Expense | $32K | -86.2% | +140.5% |
| Operating Income | -$154K | +72.1% | -35.6% |
| Pre-tax Income | $992K | +202.5% | +5225.2% |
| Income Tax | $0 | — | — |
| Net Income | $992K | +202.5% | +5225.2% |
| EPS (Basic) | $0.00 | +100.0% | — |
| EPS (Diluted) | $0.00 | +100.0% | — |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $271 | -94.1% | — |
| Accounts Receivable | $260K | +11.8% | +73.5% |
| Current Assets | $260K | +9.8% | +71.5% |
| Total Assets | $260K | +9.8% | +53.5% |
| Current Liabilities | $5.6M | -17.5% | -4.2% |
| Total Liabilities | $5.6M | -17.5% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$261K | -31.9% | — |
| Financing Cash Flow | $192K | +44.3% | — |
| -4.2% |
| Stockholders' Equity | -$5.4M | +18.5% | +6.0% |